期刊文献+

抗原冲击树突状细胞介导细胞毒性T淋巴细胞特异性抗白血病作用的体外研究 被引量:1

Specific anti-leukemic cell effect mediated by dendritic cells pulsed with acute myelogenous leukemia antigen in vitro
原文传递
导出
摘要 目的研究白血病来源树突状细胞体外诱导的有效方法;观察不同抗原诱导的特异性细胞毒性T淋巴细胞(CTL)的抗白血病效应。方法分离白血病患者骨髓单个核细胞,经钙离子载体A23187诱导分化,将弱酸洗脱抗原、低渗抗原分别冲击树突状细胞,96h后树突状细胞与T细胞共同培养,采用MTT法比较CTL细胞对白血病细胞的杀伤活性。结果骨髓来源的单个核细胞经过100ng/ml的GM—CSF、500ng/ml钙离子载体A23187成功诱导为树突状细胞,倒置显微镜下具有树突状细胞的典型形态,流式细胞术测定其CD1a、CD83表达较诱导前明显升高,差异有统计学意义(P〈0.01)。弱酸洗脱法获得抗原冲击树突状细胞致敏T细胞后杀伤白血病的能力最高,未负载抗原的树突状细胞致敏T细胞杀伤白血病细胞的能力最低,两者差异具有统计学意义(P〈0.01)。结论白血病来源的骨髓单个核细胞经GM—CSF、钙离子载体A23187能够成功诱导为树突状细胞;弱酸洗脱后获得的抗原冲击树突状细胞致敏T细胞能够获得更强的杀伤白血病细胞的能力。 Objective To explore the effective method for in vitro culture of the dendritic cells(DCs) and the specific anti-leukemic cell effect mediated by dendritic cells pulsed with acute myelogenous leukemia antigen. Methods Bone marrow mononucleas cells (BMMNCs) isolated from AML patients were induced to undergo differentiation with 500 ng/ml A23187 and pulsed with AML antigen. After 96 h, DCs and T cells were co-cultured for 5 to 7 days. The cytotoxic activity of cytotoxic T lymphocyte(CTL) to AML were detected with MTY colorimetry. Results BMMNCs isolated from AML patients treated with 100 ng/ml rhGM-CSF in combination with 500 ng/ml A23187 for 96 h exhibited typical morphology of DCs with rapidly increased expression of CD1a and CD83 (P 〈0.01). Dendritic cells pulsed with acid eluted tumor antigen peptides group displayed the strongest cytotoxic activity of CTL to AML. There was a significant difference between two groups(P 〈0.01). Conclusion BMMNCs isolated from AML patients can be successfully induced to DCs with rhGM-CSF and A23187 and dendritic cells pulsed with acid eluted tumor antigen peptides group had the strongest cytotoxic activity of CTL to AML.
出处 《白血病.淋巴瘤》 CAS 2009年第8期452-454,共3页 Journal of Leukemia & Lymphoma
关键词 白血病 树突细胞 T淋巴细胞 细胞毒性 钙离子载体 Leukemia Dendritic cells T-lymphocyte, cytotoxic Calcium ionophore
  • 相关文献

参考文献7

  • 1Delluc S, Tourneur L, Fradelizi D, et al. DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method. Cancer Immunol Immunother, 2007, 56: 1-12.
  • 2Gary KK. Gretchen NS, David EW, et al. Calcium ionophore-treated myeloid cells acquire many dendritic cell characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agents. Blood, 1999, 94: 1359-1371.
  • 3王黎明,陈珊珊,刘艳荣,付家瑜,于弘,李金兰,郭子宽.慢性髓性白血病来源的树突状细胞的功能研究[J].中国实验血液学杂志,2000,8(3):161-165. 被引量:16
  • 4Virella G. Introduction to medical immunology. NewYork: Marcel Dekker, Inc. 1998: 535-553.
  • 5William E. Paul. Fundamenlal Immunology. Lippineatt Williams & Wilkins Publishers, 2003,5: 2804-2863.
  • 6Kusmartsev S, Gabrilovich DI. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer lmmunol Immunother, 2006, 55: 237-245.
  • 7温弘,谢幸,叶大风.肿瘤诱导树突状细胞凋亡研究进展[J].国外医学(肿瘤学分册),2004,31(9):662-664. 被引量:5

二级参考文献28

  • 1Esche C, Lokshin A, Shurin GV, et al. Tumor's other immune targets:dendritic cells. J Leukoc Biol, 1999,66(2): 336-344.
  • 2Berthier VO, Gaucherand M, Peguet NJ, et al. Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells. Br J Cancer, 2001,85(12): 1944-1951.
  • 3Lee WC, Chiang YJ, Wang HC, et al. Functional impairment of dendritic cells caused by murine hepatocellular carcinoma. J Clin Immunol,2004,24(2): 145-154.
  • 4Kaufman HL, Disis ML. Immune system versus tumor: shifting the balance in favor of DCs and effective immunity. J Clin Invest, 2004, 113(5) :664-667.
  • 5Kiertscher SM, Luo J, Dubinett SM, et al. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol, 2000,164(3): 1269-1276.
  • 6Bullani RR, Wehrli P, Viard Leveugle I, et al. Frequent downregulation of Fas (CD95) expression and function in melanoma. Melanoma Res,2002,12(3) :263-270.
  • 7Restifo NP. Not so Fas: re-evaluating the mechanisms of immune privilege and tumor escape. Nature Med,2000,6(5):493-495.
  • 8Fujii S, Shimizu K, Koji F, et al. Malignant counterpart of myeloid dendritic cell (DC) belonging to acute myelogenous leukemia (AML) exhibits a dichotomous immunoregulatory potential. J Leukoc Biol, 2003, 73(1):82-90.
  • 9Buonocore S, Paulart F, Le MA, et al. Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo.Blood,2003,101 (4): 1469-1476.
  • 10Perry DK, Carton J, Shah AK, et al. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J Biol Chem,2000,275(12) :9078-9084.

共引文献19

同被引文献11

  • 1冯剑锷,孙宗全,史嘉玮,高开柱.低剂量粒巨噬细胞集落刺激因子培养小鼠骨髓源性未成熟树突状细胞的实验研究[J].中华实验外科杂志,2006,23(2):221-223. 被引量:13
  • 2Steinman RM,Hemmi H.Dendritic cells:translating innate to adaptive immunity.Curr Top Microbiol Immunol,2006,311:17-58.
  • 3Timmerman JM,Czerwinski DK,Davis TA,et al.ldiotype-pulsed dendritic cell vaccination for B-cell lymphoma:clinical and immune responses in 35 patients.Blood,2002,99:1517-1526.
  • 4Kavanagh B,Ko A,Venook A,et al.Vaccination of metastatic colorectal cancer patients with matured dendritic ceUs loaded with multiple major histocompatibility complex class I peptides.J Immnnother,2007,30:762-772.
  • 5Yu H,Babiuk LA,van Drunen Littel-van den Hurk S.Immunity and protection by adoptive transfer of dendritic cells transfected-with hepatitis C NS3/4A mRNA.Vaccine,2007,25:1701-1711.
  • 6Teleshova N,Kenney J,Robbiani M.Dendritic cells and HIV infection:activating dendritic cells to boost immunity.Adv Dent Res,2006,19:36-41.
  • 7Raimondi G,Thomson AW.Dendritic cells,tolerance and therapy of organ allograft rejection.Contrib Nephroi,2005,146:105-120.
  • 8Lutz MB,Schuler G.Immature,semi-mature and fully mature dendritic cells:which signals induce tolerance or immunity? Trends Immunol,2002,23:445-449.
  • 9Lutz MB,Suri RM,Niimi M.Immature,dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo.Eur J Immunol,2000,30:1813-1822.
  • 10Labeur MS,Roters B,Pers B,et al.Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage.J Immunol,1999,162:168-175.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部